LAVA Medtech Acquisition Corp. (LVAC) Research
LAVA Medtech Acquisition Corp. (LVAC) currently lacks significant standalone operations. Its primary objective is to secure businesses or assets through various strategic transactions, including mergers, capital stock exchanges, asset acquisitions, stock purchases, or corporate reorganizations. The firm's strategic focus is directed towards opportunities within the healthcare and allied industries. Established in 2021, the company is based in Waltham, Massachusetts, and operates as a subsidiary of LAVA Medtech Sponsor LP.
Market snapshot
- Symbol
- LVAC
- Price
- $10.43
- Day change
- 0.00%
- Market cap
- $149.9M
- P/E ratio
- 33.28x
- 52-week range
- 9.94-10.85
- Sector
- Financial Services
- Industry
- Shell Companies
Peer companies
- Blockchain Coinvestors Acquisition Corp. I (BCSA)
- Battery Future Acquisition Corp. (BFAC)
- Beard Energy Transition Acquisition Corp. (BRD)
- Forest Road Acquisition Corp. II (FRXB)
- HH&L Acquisition Co. (HHLA)
- SeaStar Medical Holding Corporation (ICU)
- Landcadia Holdings IV, Inc. (LCA)
- Cartesian Growth Corporation II (RENE)
Recent insider activity
- van der Velden Peter — trade (0 shares) on 2021-10-26
- LaPorte Fritz L — trade (0 shares) on 2021-10-26
- Natale Anthony — trade (0 shares) on 2021-10-26
Open LAVA Medtech Acquisition Corp. (LVAC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.